CME Group Inc

NASDAQ:CME

Mr. Sunil Cutinho

Chief Information Officer

Sunil Cutinho serves as the President of CME Clearing, a division of CME Group Inc. In this role, he is responsible for overseeing the risk management and clearing functions, ensuring the safeguarding and management of collateral as well as guaranteeing the integrity and financial stability of the marketplace. His leadership is critical in managing counterparty risk and protecting market participants in CME Group's clearing operations. Before assuming the President position, Cutinho held several other roles at CME Group, where he contributed significantly to technological and clearing services advancements. His background includes extensive experience in technology and operations within financial services, having led the transformation and innovation in risk management and settlement processes. Cutinho's leadership and expertise have been vital in guiding CME Clearing through changes in regulatory landscapes and in adapting to the evolving needs of the market. His work ensures that the clearing operations remain efficient, reliable, and secure, providing the foundation for one of the world's leading derivatives marketplaces.

Mr. Derek Sammann

Senior MD & Global Head of Commodities Markets

Derek Sammann is a prominent figure in the global derivatives market, known for his role at CME Group Inc., where he has made significant contributions. At CME Group, Derek Sammann serves as the Senior Managing Director and Global Head of Commodities, Options, and International Markets. In this capacity, he is responsible for the strategic leadership and growth of CME Group's options and commodity product lines, as well as the company's international business development efforts. Derek Sammann joined CME Group in 2006, bringing with him extensive experience in the industry, having held various leadership positions focused on trading, risk management, and the expansion of global markets. His unique expertise has been instrumental in driving innovation and expansion within the CME Group's diverse portfolio of products. Under his leadership, the company has seen significant advancements in the trading of options and commodities, bolstering CME Group's position as a leader in the global derivatives marketplace. Sammann's vision and strategic direction have also been pivotal in fostering international relationships and expanding CME Group's footprint in key global markets. His work is characterized by a deep understanding of the complexities of derivatives trading and a commitment to advancing CME Group's reach and influence across the globe. Derek Sammann is recognized for his strategic insight, leadership, and dedication to the growth and development of CME Group within the international financial landscape.

Michael G. Dennis serves as the Managing Director and Chief Corporate Development Officer at CME Group Inc. In this capacity, he plays a pivotal role in shaping the strategic direction of the company. His responsibilities primarily include leading mergers, acquisitions, and other strategic initiatives that are essential for the growth and expansion of CME Group in the global financial markets. Dennis is instrumental in identifying new opportunities and partnerships that align with the company's long-term objectives. With an extensive background in corporate development, Dennis has been a key figure in executing transformative transactions that enhance the company’s competitive position. Prior to his current role, he gained considerable experience in investment banking and financial services, which equipped him with the skills necessary to navigate the complex financial landscape. He is recognized for his strategic vision, leadership, and ability to drive value creation for the organization. Michael G. Dennis's contributions continue to be significant as he guides CME Group through evolving market dynamics and positions the company for sustained success in the industry.

Ms. Suzanne Sprague

Senior MD, COO & Global Head of Clearing

Suzanne Sprague is a notable executive at CME Group Inc., where she plays an important role in the company’s operations within its clearing and risk management functions. Generally, her responsibilities at CME Group may include overseeing the development and implementation of risk management strategies, ensuring the integrity and security of financial transactions processed through the exchange, and contributing to the strategic initiatives of the company. Her leadership and expertise in risk management and clearing services have been instrumental in maintaining CME Group's reputation as a leading global derivatives marketplace. Ms. Sprague's work supports the seamless functioning of futures and options trading, ensuring a robust framework for risk assessment and mitigation. Suzanne Sprague's contributions to the company have likely involved collaboration with regulatory bodies, continuous enhancement of risk management tools, and possibly innovations that drive growth and operational efficiency. Her role underscores CME Group's commitment to providing secure and reliable financial markets.

Jack Tobin serves as the Managing Director and Chief Executive Officer of CME Ventures, a subsidiary of the CME Group. In this role, he is responsible for overseeing venture capital investments and strategic initiatives. His work involves identifying innovative technologies and startups that align with the broader goals of the CME Group, which is a leading global derivatives marketplace. Tobin has a strong background in financial services and technology, contributing to his effective leadership at CME Ventures. His experiences and leadership skills play a significant role in guiding the strategic direction of the company’s investments, fostering growth, and integrating emerging tech solutions to enhance the core operations of the CME Group. His contributions are vital for maintaining the competitive edge and technological advancement of the CME Group in the global market.

John C. Peschier serves as the Managing Director of Investor Relations at CME Group Inc. He plays a crucial role in maintaining the company's relationships with the investment community, providing them with timely and accurate information regarding the company's operations, performance, and strategy. His responsibilities include overseeing the communication of financial results, strategic initiatives, and market developments to investors and analysts. Through this engagement, he helps ensure that CME Group’s valuation reflects its business prospects and achievements. Peschier’s previous experience and financial expertise contribute significantly to his role in aligning investor communications with corporate objectives.

Anita Liskey serves as the Managing Director of Corporate Marketing and Communications at CME Group Inc. In her role, she is responsible for overseeing all aspects of the company’s marketing, brand management, external and internal communications, and corporate citizenship efforts. Liskey plays a crucial part in shaping CME Group's strategic messaging and enhancing its global presence through effective communication strategies. She has been with CME Group for an extended period, contributing her extensive experience in marketing and communications to the financial services sector. Her leadership helps in promoting the company's brand and ensuring coherent communication across various platforms.

Ms. Hilda Harris Piell

Senior MD & Chief Human Resources Officer

Hilda Harris Piell is a senior executive at CME Group Inc., holding the position of Managing Director and Chief Human Resources Officer. She plays a critical role in overseeing the global human resources strategies and initiatives for the firm. Her responsibilities typically include talent acquisition and management, leadership development, employee engagement, and organizational culture. Hilda is known for her strategic leadership in aligning HR practices with the overall business goals of CME Group. Her experience and insights help drive the company's efforts to maintain a diverse and effective workforce. Prior to her role at CME Group, she has held various HR-related positions that have equipped her with a wealth of experience in the field.

Mr. Kendal Vroman

Chief Transformation Officer

Kendal Vroman is a notable executive at CME Group Inc., where he serves as the Chief Corporate Development Officer. In this role, he is responsible for leading strategic initiatives, acquisitions, and partnerships that contribute to the growth and expansion of the company's market position. Vroman plays a crucial role in exploring and executing new business opportunities, ensuring that CME Group continues to adapt and thrive in the rapidly evolving financial markets landscape. His expertise in strategy and development, along with his leadership skills, have made him a key figure in driving the company's long-term growth objectives.

Richard Romeo is the Chief Technology Officer (CTO) at CME Group Inc., a leading global derivatives marketplace. With extensive experience in information technology and financial services, Romeo is responsible for overseeing the enterprise technology strategy and ensuring the company’s systems are robust, secure, and innovative. He has played a significant role in advancing CME Group's technological initiatives, particularly in enhancing trading platforms, cybersecurity, and data analytics capabilities. His leadership contributes to the firm's ability to efficiently handle large volumes of transactions and stay competitive in the fast-paced financial markets. Romeo's career at CME Group and his contributions have been instrumental in maintaining the organization's position as a forefront leader in the global financial sector.